Zentalis Pharmaceuticals (ZNTL) Retained Earnings (2019 - 2026)
Zentalis Pharmaceuticals' quarterly Retained Earnings came in at -$1.2 billion in Q1 2026, down 11.26% year-on-year from -$1.4 billion in Q1 2025, and down 626021.94% quarter-over-quarter from $196000.0 in Q4 2025.
Zentalis Pharmaceuticals has reported Retained Earnings for 8 years, with the latest figure at -$1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 11.26% year-over-year to -$1.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 11.26% YoY), and the FY2025 full-year result was $196000.0, down 64.87% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.2 billion, down from $196000.0 in the prior quarter.
- The five-year high for Retained Earnings was $2.2 million in Q4 2023, with the low at -$1.2 billion in Q1 2026.
- Average Retained Earnings over 5 years is -$518.5 million, with a median of -$596.4 million recorded in 2022.
- Year-over-year, Retained Earnings tumbled 837372.0% in 2022 and soared 100.37% in 2023.
- Tracing ZNTL's Retained Earnings over 5 years: stood at -$596.4 million in 2022, then soared by 100.37% to $2.2 million in 2023, then slumped by 74.57% to $558000.0 in 2024, then sank by 64.87% to $196000.0 in 2025, then tumbled by 626021.94% to -$1.2 billion in 2026.
- The last three Retained Earnings figures came in at -$1.2 billion (Q1 2026), $196000.0 (Q4 2025), and $186000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Zentalis Pharmaceuticals | 280.35 Mn | 280.35 Mn | - | -1.23 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.23 Bn |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | 186,000.00 |
| Jun 30, 2025 | -1.13 Bn |
| Mar 31, 2025 | -1.10 Bn |
| Dec 31, 2024 | 558,000.00 |
| Sep 30, 2024 | -1.01 Bn |
| Jun 30, 2024 | -966.77 Mn |
| Mar 31, 2024 | -878.49 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | -827.64 Mn |
| Jun 30, 2023 | -338,000.00 |
| Mar 31, 2023 | -659.58 Mn |
| Dec 31, 2022 | -596.37 Mn |
| Sep 30, 2022 | -2.27 Mn |
| Jun 30, 2022 | -1.78 Mn |
| Mar 31, 2022 | -418.64 Mn |
| Dec 31, 2021 | -359.56 Mn |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | -305.31 Mn |
| Mar 31, 2021 | 50,000.00 |
| Dec 31, 2020 | -200.83 Mn |
| Sep 30, 2020 | -160.53 Mn |
| Jun 30, 2020 | -125.98 Mn |
| Mar 31, 2020 | -99.12 Mn |
| Dec 31, 2019 | -82.99 Mn |